Cargando…
Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
Immunotherapy with checkpoint blockers (ICBs), aimed at unleashing the immune response toward tumor cells, has shown a great improvement in overall patient survival compared to standard therapy, but only in a subset of patients. While a number of recent studies have significantly improved our unders...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326813/ https://www.ncbi.nlm.nih.gov/pubmed/32670886 http://dx.doi.org/10.3389/fonc.2020.01027 |